PRIME Model of Care in Parkinson's - A Randomised Controlled Trial

  • Research type

    Research Study

  • Full title

    Proactive and Integrated Management and Empowerment in Parkinson’s Disease (PRIME): Designing a New Model of Care – A Randomised Controlled Trial

  • IRAS ID

    283416

  • Contact name

    Emily Henderson

  • Contact email

    emily.henderson@bristol.ac.uk

  • Sponsor organisation

    University of Bristol

  • Clinicaltrials.gov Identifier

    NCT05127057

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    We aim to evaluate a new model of care termed ‘PRIME Parkinson Care’ (Proactive and Integrated Management and Empowerment in Parkinson’s) for people living with Parkinson’s, and their caregivers. Patients will be randomly allocated to either PRIME Parkinson Care, or will continue with their usual care through the NHS and other services.

    Those in the PRIME Parkinson Care (intervention) arm will receive additional support from the PRIME team to achieve their treatment goals. Care will be personalised to their particular needs and priorities: e.g. exercise, healthy eating, sleep or medication. Usual care from their Parkinson’s team will continue, but they will also be able to access PRIME Care in addition. PRIME Parkinson Care encompasses their respective caregivers who will also receive additional support through the study including invitations to workshops and peer support groups.

    Both patients and caregivers in the usual care arm will receive exactly the same care as they would if they were not in the trial. ‘Usual care’ will be provided through the NHS and other services, and participants will continue to be followed up in the usual way by their Parkinson’s consultant and nurse specialist. Written information signposting ways of accessing help through their usual team will be provided.

    Participants in both arms will be asked to complete questionnaires and speak to the study team every 3 months over the 2-year period. They will be asked to attend the hospital for an assessment visit at the start of the trial and again after 1 year and then the final visit is after 2 years. They will be sent questionnaires to complete before they attend each visit. These visits may take place in their home if appropriate. Likewise, caregivers will be asked to complete questionnaires, and attend these three hospital visits.

  • REC name

    London - Harrow Research Ethics Committee

  • REC reference

    21/LO/0387

  • Date of REC Opinion

    14 Jul 2021

  • REC opinion

    Further Information Favourable Opinion